Terbutaline Sulfate Injection Shortage
Last Updated: May 9, 2025
Status: Current
Products Affected - Description
-
- Terbutaline sulfate subcutaneous injection, Hikma, 1 mg/mL, 1 mL vial, 10 count, NDC 00143-9746-10
Reason for the Shortage
-
- Areva has terbutaline 1 mL vials available.
- Fresenius has terbutaline 1 mL vials available.
- Hikma did not provide a reason for the shortage.
Available Products
-
- Terbutaline sulfate subcutaneous injection, Areva, 1 mg/mL, 1 mL vial, 5 count, NDC 59923-0615-05
- Terbutaline sulfate subcutaneous injection, Fresenius Kabi, 1 mg/mL, 1 mL vial, 25 count, NDC 63323-0456-01
Estimated Resupply Dates
-
- Hikma has terbutaline 1 mg/mL 1 mL vials on back order and the company estimates a release date of late-June 2025.
Updated
Updated May 9, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 21, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.